Health

Matinas BioPharma Receives Notice of Non-Compliance withNYSE AmericanContinued Listing Standards

BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that…

3 weeks ago

BienRaz Launches Premium D3 + K2 Formula for Bone Health and Heart Function

NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to reveal the critical relationship between vitamin D3 and…

3 weeks ago

VigorX Pro Claims Evaluated: The VitalPro ManForceX Supplementation Method Working for Men Worldwide

Tallmadge, Ohio, April 03, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…

3 weeks ago

Vireo Growth Inc. Partners with Ace Ventures to Establish New Yorks First Minority-owned Vertically Integrated Medical Cannabis Operator

Majority ownership of Vireo Health of New York to transfer to MWBE-led Ace Ventures; partnership reinforces long-term alignment with New…

3 weeks ago

Declaration of shares and voting rights of Valneva SE March 2026

VALNEVA Declaration of shares and voting rights March 31, 2026__________________________________________________________________________________________ Company name: VALNEVARegistered office: Îlot Saint-Joseph Bureaux Convergence – Bât.…

3 weeks ago

Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer

April 03, 2026 01:00 ET  | Source: Ipsen Pharma PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces…

3 weeks ago

Cacao Bliss Claims Evaluated: The Natural GLP-1 Superfood Alternative, Earth Echo’s Chocolate Drink Mix for Weight Loss

Boulder, CO, April 02, 2026 (GLOBE NEWSWIRE) -- This release contains affiliate links. If a purchase is made through these…

3 weeks ago

Commure Introduces Dictation: AI-Powered Clinical Voice, Now at the Cursor

MOUNTAIN VIEW, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Commure today announced Commure Dictation, a speech-to-cursor extension that brings its…

4 weeks ago

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

April 02, 2026 08:00 ET  | Source: Tvardi Therapeutics HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”)…

4 weeks ago

Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment

KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today highlighted newly…

4 weeks ago